Alembic Pharmaceuticals Limited (Aplltd) (NSE: APLLTD) and Sat Kartar Life Limited (NSE: SATKARTAR) are both listed in the Non-Prescription Drugs industry. Alembic Pharmaceuticals has a market capitalisation of ₹15,784 Cr and Sat Kartar Life ₹200 Cr, as of 9 Nov 2026. Their P/E ratios are 23.4 and 11.7 respectively. Return on equity is 12.36% for Alembic Pharmaceuticals and 25.30% for Sat Kartar Life.
| Metric | Alembic Pharmaceuticals | Sat Kartar Life |
|---|---|---|
| NSE Symbol | APLLTD | SATKARTAR |
| BSE Code | 533573 | — |
| Share Price | ₹1,019.00 | ₹127.05 |
| Market Cap | ₹15,784 Cr | ₹200 Cr |
| P/E Ratio | 23.4 | 11.7 |
| Return on Equity | 12.36% | 25.30% |
| Return on Assets | 6.03% | 17.82% |
| Dividend Yield | 1.49% | 0.55% |
| Beta (1Y) | 0.29 | 0.85 |
| 1-Year Price Change | +10.3% | — |
| 3-Month Price Change | +22.6% | — |
| 52-Week Range | ₹635.80 – ₹1,055.70 | ₹126.50 – ₹130.90 |
| Latest Quarter | Q2 FY27 | — |
| Quarterly Revenue | ₹2,603 Cr | — |
| Quarterly Net Profit | ₹334 Cr | — |
| Net Margin | 12.8% | — |
| EPS (Basic, Quarter) | ₹17.05 | — |
| Results Basis | consolidated | — |
| Headquarters | Vadodara, Gujarat | New Delhi, Delhi |
The figures sit side by side and are not ranked. Quarterly figures are in ₹ crore, parsed from each company's exchange filing (XBRL); the two companies' latest quarters can differ.
Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It a…
Sat Kartar Life Limited, an ayurvedic healthcare company, provides ayurvedic products in India. The company offers ayurvedic products, vitamins, supplements, and herbal products for various health conditions, including piles, diabetes, sexual health, stamina booster, immunity booster, infertility, joint pain, hair care, addiction care, and respiratory health solutions. It also sells its products through online. The company was formerly known as Sat Kartar Shopping Limited and change its name to Sat Kartar Life Limited in February 2026. The company was incorporated in 2012 and is based in New D…
Alembic Pharmaceuticals has a market capitalisation of ₹15,784 Cr, against ₹200 Cr for Sat Kartar Life as of 9 Nov 2026, about 78.9 times the size by market cap.
Alembic Pharmaceuticals has a P/E of 23.4 and Sat Kartar Life a P/E of 11.7 as of 9 Nov 2026.
Alembic Pharmaceuticals has a return on equity of 12.36% and Sat Kartar Life 25.30%.
Both are classified under Pharmaceuticals > Non-Prescription Drugs on FinBizNet.
No. The page lays the two companies' published figures side by side and draws no conclusion from them. It is descriptive market data, not investment advice.
Data as of 9 Nov 2026. Descriptive market data only — not investment advice.